Remodulin (treprostinil) belongs to the drug class known as prostacyclin analogs. It's used for treating pulmonary arterial hypertension (PAH) in adults. It's an injection that goes under your skin or into a vein that's administered using a special pump. Side effects can include pain at the injection site, headache, and diarrhea. It's available as a brand-name and generic medication.
Pulmonary arterial hypertension (PAH)
Remodulin (treprostinil) is a prostacyclin analog, which means that it acts like prostacyclin. Prostacyclin is a natural hormone in your body that helps widen or open up the blood vessels leading to your lungs from your heart. As a result, blood can flow through these blood vessels better, which lowers the blood pressure in those vessels. This helps your body get more oxygen and your heart to work more efficiently.
Source: DailyMed
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
More common
Accumulation of blood at the site of injection
dry, red, hot, or irritated skin
feeling faint, dizzy, or lightheaded
feeling of warmth or heat
flushing or redness of the skin, especially on the face and neck
headache
redness, hardening of the skin, or rash at the site of injection
swelling
Less common
Blurred vision
confusion
dizziness, faintness, lightheadedness when getting up suddenly from a lying or sitting position
sudden sweating
unusual tiredness or weakness
Incidence not known
Black, tarry stools
bleeding gums
blood in the urine or stools
bone pain
changes in skin color, pain, tenderness, or swelling of the foot or leg
decreased urine output
difficult or labored breathing
dilated neck veins
extreme tiredness or weakness
irregular breathing
irregular heartbeat
itching, pain, redness, swelling, or tenderness on the skin
paleness of the skin
pinpoint red spots on the skin
tightness in the chest
troubled breathing
unusual bleeding or bruising
Get emergency help immediately if any of the following symptoms of overdose occur:
Symptoms of overdose
Loss of consciousness
seizure
unusual tiredness or weakness
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
One of the first choices for treating certain people at risk for worsening PAH
Can help improve PAH symptoms during exercise (e.g., how far you can walk in a given amount of time, shortness of breath)
Dose adjustments can be made based on your response
Doesn't cure PAH
Injected under the skin or into a vein
Can cause pain at the injection site
Your provider will give you directions on how to prepare and infuse Remodulin (treprostinil). You might need to mix it with another liquid (called a diluent) before you use it for your infusion. Your healthcare provider will let you know if and how your medication needs to be mixed with a diluent.
Before you use Remodulin (treprostinil) for your infusion, make sure the solution doesn't have any flakes in it and that it's clear. Otherwise, don't use the medication; it could be contaminated with germs, and it won't be safe for you to use.
Don't lower the Remodulin (treprostinil) dose that was prescribed to you or suddenly stop taking the medication without speaking to your healthcare provider. Otherwise, your PAH symptoms might worsen and cause shortness of breath, dizziness, or unusual weakness.
Make sure you have a backup pump in case your infusion pump stops working.
Remodulin (treprostinil) can raise your risk of bleeding. Let your healthcare provider know and get medical help if you notice a cut or any bleeding that takes longer to stop or doesn't stop.
Throw away any Remodulin (treprostinil) vials that have been opened or stuck with a needle after 30 days.
Remodulin (treprostinil) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Infusing Remodulin (treprostinil) into a vein
Infusing Remodulin (treprostinil) into your vein for a long time can potentially put you at risk for bloodstream infections. These infections can sometimes be life-threatening. To lower your risk of infections, wash your hands before you use Remodulin (treprostinil). Make sure that the area by your catheter is clean and pain-free. It's preferred to infuse the medication underneath your skin because there's a lower risk of bloodstream infections when the medication is given this way.
Your symptoms of PAH can worsen if you lower your dose or stop taking Remodulin (treprostinil) suddenly. Make sure you have a backup infusion pump in case your pump stops working during administration. Don't lower your dose or stop taking the medication without talking to your provider first. Your provider should give you instructions how to do so safely.
Your liver helps break down Remodulin (treprostinil) in your body. Having liver problems can affect your body's ability to clear the medication, which can lead to higher levels of Remodulin (treprostinil) in your body. This can lead to more unwanted side effects. Let your healthcare provider know if you have a history of liver problems before you start Remodulin (treprostinil). Your dose might need to be adjusted to make sure you're safe.
Risk factors: History of low blood pressure | Taking medications that lower blood pressure
Remodulin (treprostinil) can cause your blood pressure to drop because medication helps relax and widen your blood vessels. Low blood pressure can sometimes lead to symptoms like dizziness or feeling faint. Let your provider know if you feel dizzy or lightheaded while you're taking this medication.
The dose depends on your body weight. The typical starting dose is 1.25 nanograms (ng)/kg of weight per minute. It's injected underneath your skin or into a vein using a special pump. Your healthcare provider will prescribe the right dose for you and explain how to use the pump.
Your dose might differ if you have liver problems.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Pulmonary arterial hypertension (PAH)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Humbert, M., et al. (2022). 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). European Heart Journal.
Kuwana, M., et al. (2023). Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension. Pulmonary Circulation.
McLaughlin, V. V., et al. (2003). Efficacy and safety of treprostinil: An epoprostenol analog for primary pulmonary hypertension. Journal of Cardiovascular Pharmacology.
Mitchell, J. A., et al. (2014). Role of prostacyclin in pulmonary hypertension. Global Cardiology Science & Practice.
Narechania, S., et al. (2019). Treatment discontinuation or interruption in pulmonary arterial hypertension. Journal of Cardiovascular Pharmacology and Therapeutics.
United Therapeutics Corporation. (2023). Remodulin- treprostinil injection, solution; Sterile diluent for Remodulin- water injection, solution [package insert]. DailyMed.
United Therapeutics Corporation. (n.d.). Offering options to help make living with a pump easier.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.